BG4.BE - Barnes Group Inc
Chart Events
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 38.60 |
| Open | 38.00 |
| Bid | 33.00 x 0 |
| Ask | 34.00 x 0 |
| Day's Range | 38.00 - 38.00 |
| 52 Week Range | 29.00 - 42.60 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Jul 27, 2023 - Jul 31, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
BenzingaBarnes Buys MB Aerospace For $740M, Its Largest Acquisition Ever
Barnes Group Inc (NYSE: B) has agreed to acquire MB Aerospace for an enterprise value of approximately $740 million. MB Aerospace offers precision aero-engine component manufacturing and repair services serving aerospace and defense engine companies. MB Aerospace maintains its corporate headquarters in Motherwell, U.K., with an additional 10 facilities and approximately 1,450 employees across the U.S., U.K., Poland, and Taiwan. Barnes expects the effective purchase price multiple to be around 11
Business WireBarnes to Acquire MB Aerospace
BRISTOL, Conn., June 05, 2023--Barnes Group Inc. (NYSE: B) today announced that it has entered into a definitive agreement to acquire MB Aerospace ("MB"). MB Aerospace is a leading provider of precision aero-engine component manufacturing and repair services serving major aerospace and defense engine OEMs, Tier 1 suppliers, and MRO providers for an enterprise value of approximately $740 million. The transaction is expected to close in the fourth quarter of 2023, subject to the receipt of regulat
Simply Wall St.Barnes Group (NYSE:B) Is Paying Out A Dividend Of $0.16
Barnes Group Inc.'s ( NYSE:B ) investors are due to receive a payment of $0.16 per share on 9th of June. This payment...
PR NewswireMarketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic
BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that they have submitted a Marketing Authorisation Application (MAA) for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer's disease[2] (AD) with confirmed amyloid pathology in the brain, to the UK Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain. Lecanemab has been designated by the MHRA for the Innovative Licensing and Access
PR NewswireSocietal value of lecanemab in Japan published in Neurology and Therapy
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced the publication of results from a simulation study evaluating the societal value of lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer's disease[2], in the context of the Japanese health care system in the peer-reviewed journal Neurology and Therapy. The paper concluded that lecanemab treatment would improve health and h
PR NewswireGrupo Simec Files Its Form 20-F For The 2022 Financial Year
Grupo Simec, S.A.B. de C.V. (NYSE-MKT: SIM and BMV: SIMEC-B) (the "Company") today filed its Annual Report on Form 20-F for the year ended December 31, 2022 with the U.S. Securities and Exchange Commission at www.sec.gov. The Form 20-F is also available on the investor relations section of the Company's website at https://gsimec.com.mx/sec-filings.php. Shareholders may request a hard copy of the Form 20-F, including the Company's complete audited financial statements for the year ended December
Business WireBarnes Reports First Quarter 2023 Financial Results
BRISTOL, Conn., April 27, 2023--Barnes Group Inc. (NYSE: B), a global provider of highly engineered products, differentiated industrial technologies, and innovative solutions, today reported financial results for the first quarter 2023.
- Simply Wall St.
Barnes Group Inc. (NYSE:B) insiders have a reason to boast after seeing a US$265k addition to their US$2.8m investment
Last week, Barnes Group Inc. ( NYSE:B ) insiders, who had purchased shares in the previous 12 months were rewarded...
PR NewswireLong-term health outcomes for lecanemab using simulation model and Phase 3 Clarity AD data published
BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today announced that its partner Eisai has published an article about long-term health outcomes of anti-amyloid-beta (Aβ) protofibril[1] antibody lecanemab in people living with mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD (collectively known as early AD) using a disease simulation model in the peer-reviewed journal Neurology and Therapy. In this simulation, lecanemab treatment is estimated to potentially slow the rate
PR NewswireBioArctic: New lecanemab-data presented at the AD/PD™ 2023 conference
BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) and its partner Eisai has presented new findings on lecanemab (generic name, U.S. brand name: LEQEMBI™), an anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer's disease (AD), at the 2023 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders (AD/PD™). The presentations included analyses of amyloid-related imaging abnormalities (ARIAs) with antiplatelet and anticoagulant therapy, th
Business WireBarnes Announces First Quarter 2023 Earnings Conference Call and Webcast
BRISTOL, Conn., March 15, 2023--Barnes Group Inc. (NYSE: B) today announced it will release first quarter 2023 financial results on Thursday, April 27, 2023, before the market opens.
Insider MonkeyBarnes Group Inc. (NYSE:B) Q4 2022 Earnings Call Transcript
Barnes Group Inc. (NYSE:B) Q4 2022 Earnings Call Transcript February 17, 2023 Operator: Good morning. My name is Devin and I will be your conference operator today. At this time, I would like to welcome everyone to the Barnes Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast. All lines have been placed […]
- Simply Wall St.
Barnes Group Full Year 2022 Earnings: EPS Misses Expectations
Barnes Group ( NYSE:B ) Full Year 2022 Results Key Financial Results Revenue: US$1.26b (flat on FY 2021). Net income...
BenzingaBarnes Clocks ~1% Sales Growth In Q4 Amid Persistent Pressures In Industrial Segment
Barnes Group Inc (NYSE: B) reported fourth-quarter FY22 sales growth of 1% year-over-year at $313.5 million, +5% on an organic basis, missing the consensus of $322.6 million. Adjusted EPS of $0.52 beat the consensus of $0.49. Operating income declined 31.7% Y/Y to $24.2 million due to pressures in its Industrial segment. Industrial segment sales decreased by 2.5% Y/Y to $204.97 million, and Aerospace segment sales increased by 7.7% Y/Y to $108.50 million. Aerospace OEM backlog was at $750 millio
Business WireBarnes Reports Fourth Quarter and Full Year 2022 Financial Results
BRISTOL, Conn., February 17, 2023--Barnes Group Inc. (NYSE: B), a global provider of highly engineered products, differentiated industrial technologies, and innovative solutions, today reported financial results for the fourth quarter and full year 2022.
- Simply Wall St.
Here's Why We're Wary Of Buying Barnes Group's (NYSE:B) For Its Upcoming Dividend
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Barnes Group...
- Simply Wall St.
Barnes Group's (NYSE:B) Dividend Will Be $0.16
The board of Barnes Group Inc. ( NYSE:B ) has announced that it will pay a dividend on the 10th of March, with...
Business WireBarnes Declares Quarterly Dividend
BRISTOL, Conn., February 10, 2023--The Board of Directors of Barnes Group Inc. (NYSE: B) has declared a quarterly cash dividend of sixteen cents ($0.16) per share. The dividend will be payable March 10, 2023, to shareholders of record at the close of business on February 23, 2023.
Business WireBarnes Group Inc. Appoints Neal J. Keating to Board of Directors
BRISTOL, Conn., February 09, 2023--Barnes Group Inc. (NYSE: B), a global provider of highly engineered products, differentiated industrial technologies, and innovative solutions, today announced the appointment of Neal J. Keating to the Company’s Board of Directors, effective February 9, 2023. Mr. Keating has also been appointed to the Company’s Corporate Governance Committee.
- Simply Wall St.
A Look At The Fair Value Of Barnes Group Inc. (NYSE:B)
How far off is Barnes Group Inc. ( NYSE:B ) from its intrinsic value? Using the most recent financial data, we'll take...
- Simply Wall St.
What Is Barnes Group Inc.'s (NYSE:B) Share Price Doing?
While Barnes Group Inc. ( NYSE:B ) might not be the most widely known stock at the moment, it led the NYSE gainers with...
- Simply Wall St.
Capital Allocation Trends At Barnes Group (NYSE:B) Aren't Ideal
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
Business WireBarnes Announces Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast
BRISTOL, Conn., December 15, 2022--Barnes Group Inc. (NYSE: B) today announced it will release fourth quarter and full year 2022 financial results on Friday, February 17, 2023, before the market opens.
- Simply Wall St.
The past five years for Barnes Group (NYSE:B) investors has not been profitable
It is doubtless a positive to see that the Barnes Group Inc. ( NYSE:B ) share price has gained some 35% in the last...
- Simply Wall St.
Barnes Group Inc.'s (NYSE:B) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Barnes Group (NYSE:B) has had a great run on the share market with its stock up by a significant 38% over the last...